| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $719,345,297 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01HG014145 | Enhancing Access to Genomic Expertise: A Comprehensive Implementation Strategy for the Western Regional Genomic eConsult Network (WestGEN) | 001 | 1 | NIH | 5/5/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01HG014145 | Enhancing Access to Genomic Expertise: A Comprehensive Implementation Strategy for the Western Regional Genomic eConsult Network (WestGEN) | 000 | 1 | NIH | 2/27/2026 | $2,825,743 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 006 | 1 | NIH | 6/10/2026 | -$16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K00AG097172 | The Disadvantage Exposome as a Driver of Alzheimer’s Disease Pathology | 000 | 3 | NIH | 6/17/2026 | $86,835 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 005 | 1 | NIH | 5/22/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01EY038907 | Defining area-specific cellular and circuit-level specialization in the human temporal cortex | 000 | 1 | NIH | 6/30/2026 | $737,998 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K08CA300872 | Trauma-Informed Smoking Cessation for Women | 000 | 1 | NIH | 7/2/2026 | $306,304 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99AG097973 | Mapping cerebellar influence in FTD: unraveling the role of the cerebellum in social cognition and clinical trajectory | 000 | 1 | NIH | 2/27/2026 | $119,785 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 004 | 1 | NIH | 5/21/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 003 | 1 | NIH | 5/21/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21HD118709 | PHARMA-GIRL: Empowering adolescent girls and young women with choice and prevention in pharmacy-based HIV interventions | 002 | 1 | NIH | 2/5/2026 | $7,367 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 002 | 1 | NIH | 5/21/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21HD118709 | PHARMA-GIRL: Empowering adolescent girls and young women with choice and prevention in pharmacy-based HIV interventions | 001 | 1 | NIH | 1/30/2026 | $56,523 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AT013214 | Assessing multi-site feasibility of an integrated whole-body hyperthermia and behavioral intervention for major depressive disorder | 000 | 1 | NIH | 4/16/2026 | $601,259 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 001 | 1 | NIH | 5/13/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21HD118709 | PHARMA-GIRL: Empowering adolescent girls and young women with choice and prevention in pharmacy-based HIV interventions | 000 | 1 | NIH | 1/26/2026 | $144,115 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 000 | 1 | NIH | 5/11/2026 | $492,815 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21HD118709 | PHARMA-GIRL: Empowering adolescent girls and young women with choice and prevention in pharmacy-based HIV interventions | 003 | 1 | NIH | 2/9/2026 | -$56,523 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21AR085253 | Using In Vitro Culture to Detect Changes in Bone Matrix Mechanical Properties | 000 | 2 | NIH | 8/11/2026 | $162,628 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99ES038229 | Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smoke Exposure Reduction Strategies on Respiratory Health | 000 | 1 | NIH | 4/16/2026 | $117,747 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21HD118709 | PHARMA-GIRL: Empowering adolescent girls and young women with choice and prevention in pharmacy-based HIV interventions | 003 | 1 | NIH | 2/9/2026 | $56,523 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI200744 | Modeling dynamic CD8+ T cell-virus interactions in post-treatment control of HIV | 000 | 1 | NIH | 5/11/2026 | $874,531 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R35GM158447 | Bridging the Gap Between Prediction and Reality in Structural Biology | 000 | 2 | NIH | 5/25/2026 | $451,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01HL177070 | Molecular Mechanisms Controlling Lung Capillary Speciation, Plasticity and Function During Early Postnatal Development | 000 | 1 | NIH | 7/2/2026 | $778,504 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 014 | 1 | NIH | 8/25/2026 | $50,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01DK142372 | Patient provider communication and disparities in access to home dialysis and kidney transplantation | 000 | 2 | NIH | 8/18/2026 | $793,874 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K23DK141906 | Use of the electronic health record to target a patient navigation intervention preventing loss to follow up in the treatment of urinary stone disease | 000 | 2 | NIH | 7/1/2026 | $178,729 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 013 | 1 | NIH | 7/21/2026 | $16,740 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31AI200462 | Elucidating the biophysical basis of repeatability in the evolution of drug resistance | 001 | 1 | NIH | 5/11/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F99EB037629 | Developing Interpretable Predictive Models Using Patient Specific Imaging and Clinical Biomarkers with Missing Data | 000 | 1 | NIH | 5/12/2026 | $48,357 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 012 | 1 | NIH | 7/20/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31AI200462 | Elucidating the biophysical basis of repeatability in the evolution of drug resistance | 000 | 1 | NIH | 5/11/2026 | $44,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01CA316038 | Overcoming medulloblastoma resistance to treatment using in vivo perturb-seq and preclinical therapeutics | 000 | 1 | NIH | 7/2/2026 | $680,600 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 011 | 1 | NIH | 7/17/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01NS148534 | Striatal Synaptic Plasticity in the Cognitive Aspects of Parkinsons Disease | 000 | 1 | NIH | 5/19/2026 | $595,208 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21DE035693 | Inhibition vs. promotion of intrafibrillar mineralization of collagen fibrils | 000 | 1 | NIH | 8/7/2026 | $451,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01MH144052 | Autism-Associated Synaptic Protein SYNGAP1 at the Cilium | 000 | 1 | NIH | 8/13/2026 | $568,746 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K01DK146279 | Evaluating telemedicine use for urinary tract infections among adolescent and young adult women | 000 | 1 | NIH | 8/17/2026 | $160,692 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21AG104396 | An Overlooked Steroid Hormone as a Driver of Cognitive Resilience | 000 | 1 | NIH | 8/17/2026 | $451,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01CA316800 | Precision Imaging of Cardiotoxicity: Metabolic MR Biomarkers for Pathophysiology, Early Detection, and Cardioprotection Effect Monitoring | 000 | 1 | NIH | 8/12/2026 | $635,782 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01HL185359 | Genetic and Molecular Mechanisms of PGE2-EP4-Induced Goblet Cell Metaplasia in Asthma | 000 | 1 | NIH | 8/19/2026 | $3,205,321 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99HD120651 | Granulosa-derived RNAs as targets for oocyte rejuvenation | 000 | 1 | NIH | 8/18/2026 | $123,147 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI196061 | Longitudinal evaluation of interactions between variable PfEMP1 virulence genes, the anti-PfEMP1 antibody repertoire, and outcomes of naturally occurring Plasmodium falciparum infections | 000 | 1 | NIH | 8/18/2026 | $816,441 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01HL186881 | Immune exhaustion, Telomere and Immune Response Effects on DLco in HIV– The I’M TIRED-HIV Study | 000 | 1 | NIH | 8/6/2026 | $813,499 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01CA316736 | Mechanisms of BCMA CAR-T-mediated enteritis in multiple myeloma patients | 000 | 1 | NIH | 8/12/2026 | $683,270 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21CA318322 | Combining alpha-Particle Radioimmunotherapy and Antibody–Drug Conjugates to Improve Outcomes in Pancreatic Cancer | 000 | 1 | NIH | 8/6/2026 | $420,943 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI202121 | Cell signaling determinants of human Treg persistence | 000 | 1 | NIH | 8/17/2026 | $813,236 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R03HL180982 | Variation in Chest Pain Admission Among Emergency Department Clinicians and Its Impact on Subsequent Testing and Patient Outcomes | 000 | 1 | NIH | 8/17/2026 | $246,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31MH146127 | Towards a multimodal model of neuronal diversity in the human cerebral cortex | 000 | 1 | NIH | 8/5/2026 | $43,479 |
|
